CRO, LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	4	1
2024	—	4	1
2023	—	5	1
2022	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BUCHANAN INGERSOLL & ROONEY PC	—	18

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	6
SENATE	6
Defense, Dept of (DOD)	3
Food & Drug Administration (FDA)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	7
Budget/Appropriations	Budget/Appropriations	7
Defense	Defense	7
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	7

Bills Explicitly Cited (6)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2024 · second_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2024 · second_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2024 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2024 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

Show 2 more cited filings

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2023 · fourth_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

S. 2333118th Congress

Pandemic and All-Hazards Preparedness and Response Act

2023 · fourth_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC

Open original LDA filing ↗

Cited source text and reported amounts

Strategy development and implementation of federal government relations initiatives relating to antivenom biologic products. Pandemic All-Hazards Preparedness and Response Act (S.2333)

Client expense: — · Firm income: $20,000

Matched citations: S.2333

Source: Senate LDA

CRO, LLC — Lobbying Disclosure | Poliscope